Hepatitis B Vaccine Market Size, Share, Growth and Forecast 2030
The Hepatitis B Vaccine Market is experiencing continued growth as governments and healthcare organizations expand immunization programs aimed at preventing hepatitis B virus (HBV) infections.
According to Market Research Future, the market is projected to grow significantly during the forecast period, supported by government birth-dose mandates, increasing awareness of hepatitis B prevention, vaccination programs in emerging economies, and expanding adult vaccination initiatives.
Pediatric immunization remains a major contributor to market demand, particularly because timely vaccination at birth is an important strategy for reducing mother-to-child transmission. At the same time, adult vaccination is gaining momentum through occupational, high-risk, and catch-up vaccination programs.
Technological developments are also influencing the market. Recombinant vaccine technologies have become widely established, while combination vaccines, prefilled syringes, and needle-free delivery technologies are creating additional opportunities.
North America remains a major regional market, while Asia-Pacific is expected to experience strong growth as countries expand birth-dose coverage and strengthen national immunization programs.
Overall, increasing vaccination coverage, government initiatives, and innovations in vaccine delivery are expected to support the long-term expansion of the global hepatitis B vaccine industry.